A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery

Hematoma Postoperative Clinical Trial

Official title:
A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery

Status Recruiting

Clinical Trial Summary

This trial is being completed to evaluate the safety and efficacy of topical tranexamic acid use in preventing hematomas in routine breast plastic surgery operations.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05441592
Study type	Interventional
Source	University of Michigan
Contact	Sherry Tang, MD
Phone	734-936-5895
Email	syqtang@med.umich.edu
Status	Recruiting
Phase	Phase 4
Start date	August 15, 2022
Completion date	June 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03738527` - SEroma Reduction pOst MAstectomy "SEROMA Study"	Phase 4
Completed	`NCT04947514` - Use of Tranexamic Acid in Reduction Mammoplasty	Phase 4
Not yet recruiting	`NCT04389398` - Prevention of Pocket Hematoma After Implantation Cardiovascular Implanted Electronic Devices	N/A
Completed	`NCT04559646` - Application of the "Haemoblock" in Pacemaker Patients
Recruiting	`NCT03535116` - The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery	Phase 4
Not yet recruiting	`NCT04918576` - Topical Tranexamic Acid for Bilateral Breast Reduction Surgery	Phase 3
Not yet recruiting	`NCT04918589` - Tranexamic Acid for Alloplastic Breast Reconstruction	Phase 3
Active, not recruiting	`NCT04554407` - Study to Evaluate the Performance of a Sustained Vacuum System	N/A